Abstraction Health

Tongkat Ali — Research Evidence

Source: PubMed / NCBI · human studies preferred · ranked by evidence qualityLast analyzed: May 24, 2026
Insufficient Evidence
4 studies·1 RCTs·3 reviews

The summary below was generated by an AI system (Claude) based on the studies listed. It is a synthesis tool, not a clinical opinion. Read individual studies for full context.

The current evidence base for Tongkat Ali (Eurycoma longifolia Jack) is limited and largely insufficient to support most of the health claims commonly made about this supplement. Across four studies reviewed — including two systematic reviews, one narrative review, and one randomized controlled trial — the vast majority of evaluated claims (10 out of 11) were rated as having insufficient evidence, with only one claim — that Tongkat Ali is a root extract from a Southeast Asian shrub with a long history of traditional medicinal use — receiving even partial support. This reflects a pattern common to many traditional herbal supplements: cultural and historical use is well-documented, but rigorous clinical evidence remains sparse.

The one RCT identified examined the effects of Tongkat Ali over six months in aging males with androgen deficiency (ADAM), using a double-blind, placebo-controlled design alongside concurrent exercise training. While this trial design is methodologically sound in principle, its quality was rated as moderate, and the combination with exercise training makes it difficult to isolate the specific contribution of the supplement. Systematic reviews also examined Tongkat Ali in the context of erectile dysfunction supplements more broadly, with findings suggesting that popular online products in this category frequently lack robust clinical support. The narrative review provides background on traditional uses and chemistry, but moderate-quality reviews of this type cannot substitute for controlled human trials.

Several important caveats limit what can be concluded. None of the study records provided included specific quantitative findings, population sizes, or detailed limitations data, which significantly constrains interpretation. Key unknowns include optimal dosing, long-term safety, effects in healthy populations versus those with diagnosed deficiencies, and whether any observed benefits are attributable to the supplement itself versus co-interventions like exercise. The gap between traditional use and clinical validation remains wide, and consumers should be cautious about marketing claims that outpace the science.

Key findings

  • Tongkat Ali has a well-documented history of traditional use in Southeast Asian medicine, particularly for male vitality — this historical context is the most consistently supported claim in the literature reviewed.
  • One moderate-quality RCT examined Tongkat Ali's effects on erectile function and testosterone in aging males with androgen deficiency, but the co-administration of an exercise program makes it difficult to attribute any effects solely to the supplement.
  • Systematic review evidence suggests that Tongkat Ali, like many popular erectile dysfunction supplements sold online, lacks strong clinical trial support for its marketed benefits.
  • 10 out of 11 expert claims evaluated about Tongkat Ali were rated as having insufficient evidence, indicating a significant gap between popular health claims and scientific substantiation.

Evidence gaps

  • ?There is a near-total absence of large, well-controlled human trials isolating Tongkat Ali's effects from confounding factors like exercise, making it impossible to draw firm conclusions about efficacy.
  • ?Optimal dosage, standardization of active compounds (e.g., eurycomanone), and long-term safety data in humans are not established by the studies reviewed.
  • ?Research has focused narrowly on androgen-deficient aging males, leaving unknown whether any effects generalize to healthy adults or other populations.

Safety summary

The reviewed studies do not provide sufficient clinical data to fully characterize the safety profile of Tongkat Ali in humans. While traditional use suggests general tolerability, formal toxicology data from rigorous human trials is lacking based on the evidence available here.

Studies (4)

Medicina (Kaunas, Lithuania) · 2022 · Leisegang K et al.
Systematic Review🟢
Key finding

COI: The authors declare no conflict of interest.
PMID: 36013514DOI: 10.3390/medicina58081047
View on PubMed

An Analysis of Popular Online Erectile Dysfunction Supplements.

The journal of sexual medicine · 2019 · Balasubramanian A et al.
Systematic Review🟢
Key finding

An Analysis of Popular Online Erectile Dysfunction Supplements.

Funded by: NIDDK NIH HHS
PMID: 31036522DOI: 10.1016/j.jsxm.2019.03.269
View on PubMed

A 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM).

Maturitas · 2021 · Leitão AE et al.
RCT🟡
Key finding

A 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM).

PMID: 33541567DOI: 10.1016/j.maturitas.2020.12.002
View on PubMed

Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology.

Molecules (Basel, Switzerland) · 2016 · Rehman SU et al.
Review🟡
Key finding

Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology.

Funded by: Industry (inferred from affiliations)
COI: The authors declare no conflict of interest.
PMID: 26978330DOI: 10.3390/molecules21030331
View on PubMed